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Peripheral blood mononuclear cells (PBMC) from three adult male squirrel monkeys (SaıF miri sciureus) were transformed
by human T-cell leukemia/lymphoma virus type I (HTLV-I) by cocultivation with lethally irradiated human MT-2 cells. Three
permanent monkey T-cell lines producing HTLV-I were obtained and characterized. Six weeks after inoculation seroconver-
sion was observed in three of three monkeys inoculated with autologous transformed T cells and in two of three monkeys
receiving homologous cells. Proviral DNA was detected in their PBMC at various times after inoculation, with the highest
proviral load and antibody titers being found in monkeys infected with homologous cells. Monkeys inoculated with heterolo-
gous MT-2 cells did not seroconvert, and HTLV-I provirus was detected only transiently in their PBMC. To determine whether
in vitro and in vivo HTLV-I infection of squirrel monkey cells led to a selection of monkey-adapted viral mutants, comparative
sequencing of the proviral gp21 env between ex vivo monkey HTLV-I-infected PBMC, the inoculum, and MT-2 cells was
done and no significant differences were detected. The squirrel monkey, which is naturally free of simian T-cell leukemia/
lymphoma virus, thus appears to be a suitable model for evaluating HTLV-I candidate vaccines and for studying the
pathogenesis of HTLV-I. q 1997 Academic Press
infection by immunization with recombinant HTLV-I EnvINTRODUCTION
protein (Nakamura et al., 1987; Dessutti et al., 1990).
The aim of the present work was to study further exper-Animal models of infection with human T-cell leuke-
imental HTLV-I infection of the squirrel monkey (SaıF mirimia/lymphoma virus type I (HTLV-I) are most useful for
sciureus), a New World species that is free of simian T-studying host–virus interactions and the pathogenesis
cell leukemia/lymphoma viruses (STLVs), and to test itof associated diseases, such as adult T-cell leukemia
as a possible experimental model for pathogenesis and(Poiesz et al., 1980; Yoshida et al., 1984) and tropical
vaccine development. Nakamura et al. (1986) tested thespastic paraparesis/HTLV-I-associated myelopathy
susceptibility of squirrel monkeys to HTLV-I infection by(Gessain et al., 1985). They are also essential for testing
inoculation with autologous (syngeneic) cells trans-candidate vaccines (Bomford et al., 1996; de The´ and
formed by HTLV-I. We have compared the efficacy ofKazanji, 1996). Chronic HTLV-I infections have been in-
autologous (syngeneic), homologous (allogeneic), andduced in both the rabbit (Miyoshi et al., 1985; Cockerell
heterologous (xenogeneic) HTLV-I-transformed cells toet al., 1990; Lairmore et al., 1992) and the rat (Yoshiki et
infect squirrel monkeys with HTLV-I. The correlation be-al., 1987; Suga et al., 1991; Ishiguro et al., 1992; Ibrahim
tween the proviral load and the immune response waset al., 1994).
also investigated. Finally, we assessed the genomic sta-Several species of nonhuman primates have also been
bility of HTLV-I after inoculation into a nonnatural host,found to be susceptible to infection by HTLV-I. Marmo-
to determine whether HTLV-I infection in the squirrelsets (Callithrix jacchus) were infected orally by the milk
monkey is accompanied by selection of monkey-adaptedof HTLV-I-carrying women (Yamanouchi et al., 1985). Cy-
viral mutants.nomolgus macaques (Macaca fascicularis) and pig-tailed
macaques (Macaca nemestrina) were protected against
MATERIALS AND METHODS
Animals and transformation of monkey peripheralSequence data from this article have been deposited with the EMBL/
blood mononuclear cells by HTLV-IGenBank Data Libraries under Accession Nos. U73973–U74016.
1 To whom correspondence and reprint requests should be ad-
Eight 9-year-old male squirrel monkeys (S. sciureus)dressed at Unite´ d’Epide´miologie des Virus Oncoge`nes, Institut
from the breeding primate center of the Pasteur InstitutePasteur, 28, rue du Dr Roux, 75724 Paris Cedex 15, France. Fax: 33
0145688931. E-mail: dethe@pasteur.fr. of French Guiana were used. Preliminary serological ex-
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amination confirmed that the animals were free of STLV monkey cell lines. The cells were then fixed and
stained with 5-bromo-4-chloro-3-indolyl b-D-galacto-and HTLV-I/II (data not shown). Moreover, high-molecu-
lar-weight DNA was extracted from the peripheral blood pyranoside (X-gal) for up to 4 hr. Blue spots revealed
fusion between the P4 cells, the HTLV-I env expressingmononuclear cells (PBMCs) of all the monkeys before
inoculation and PCR was done by using primers Env1- cells, and the cell line producing Tat.
Env22, which were shown to amplify all the different
Inoculation of monkeys with HTLV-I-producing cellsHTLV-I/STLV-I subtypes (Koralnik et al., 1994). Polymer-
ase chain reaction (PCR) products were then transferred
Three monkeys were inoculated intravenously with 108
and membranes hybridized with specific probes.
autologous HTLV-I-transformed producing cells, three
In order to immortalize monkey cells lines with HTLV-
further monkeys with 107 homologous HTLV-I-producing
I, 106 PBMCs from the three monkeys were cocultivated
monkey cell lines, and two monkeys with 107 heterolo-
with an equal number of lethally irradiated (10,000 rad)
gous MT-2 cells. The protocol is summarized in Table 2.
MT-2 cells under the usual conditions: RPMI 1640 with
Every 2 weeks after inoculation, blood samples were
20% heat-inactivated fetal calf serum, 1% L-glutamine and
taken and each monkey was examined for visible signs
1% penicillin/streptomycin (Flow Labs, Scotland) supple-
of lymphoid malignancy.
mented with 20 U/ml of recombinant interleukin-2 (Boeh-
HTLV-I antibodies in the serum of the inoculated mon-
ringer, Germany), with biweekly changes.
keys were measured by ELISA (Diagnostic Biotechnol-
ogy, Singapore) and confirmed by Western blot assayImmunovirological and molecular studies
(HTLV-I; 2.3 Diagnostic Biotechnology). HTLV-I proviral
copies in PBMC from infected monkeys were quantifiedTo detect p19 and p24 viral antigen expression, an
indirect immunofluorescence assay was performed on by the method described by Cimarelli et al. (1995). Briefly,
competitive PCR tests were performed on genomic DNAthe cultured cells using either mouse monoclonal anti-
bodies directed against these antigens (Cambridge Bio- purified from PBMC of infected monkeys obtained 3, 6,
and 12 months after inoculation. The number of HTLV-Itech, USA) or polyclonal sera from HTLV-I-infected indi-
viduals. FACS analysis (kindly performed by Dr. F. Va- copies was determined in 0.7 mg of DNA, corresponding
to the amount of genomic DNA extracted from 105 PBMC.lensi, Hoˆpital Necker, Paris, France) of the cultured cells
was undertaken with different monoclonal antibodies di- Ten months after inoculation, PBMC from the infected
monkeys were cultured, and the supernatants were ana-rected against human T-cell and B-cell antigens, as pre-
viously described (Mahieux et al., 1994). The production lyzed by an antigen capture assay (Retro-tek, HTLV p19
antigen ELISA; Cellular Products Inc., USA) that can de-of p19 core antigen in the cultures supernatant was mea-
sured by a capture ELISA assay (Retro-tek HTLV p19 tect at least 25 pg/ml of the major core antigen gag p19
of HTLV-I.antigen ELISA, Cellular Products, USA) that detects
HTLV-I, STLV-I, and HTLV-II p19.
Polymerase chain reactionHigh-molecular-weight DNA was extracted from the
HTLV-I-transformed squirrel monkey cell lines. After di-
In order to prevent PCR contamination, genomic DNA
gestion by EcoRI restriction enzymes, the restricted frag-
was extracted in the Pasteur Institute of French Guiana,
ments were separated by electrophoresis, transferred to
where HTLV-I has never been either amplified or cloned.
nylon filters, and hybridized with either the PMT-3 sub-
During PCR all steps were performed using positive dis-
cloned PstI fragment of the PMT-2 clone or the 1711
placement pipettes. The mixtures and the PCR were per-
total HTLV-I genomic probe (kindly provided by Dr. G.
formed by two different researchers in three different,
Franchini, NIH, Bethesda, MD), as described by Gessain
physically separate rooms. Two different negative PCR
et al. (1992a).
controls were used for each experiment. PCR (35 cycles)
or seminested PCR was performed on genomic DNASyncitium formation assay
extracted from PBMC or various organs, according to the
method described by Ibrahim et al. (1994). Single PCRAs previously described by Clavel et al. (1994), the
syncitium formation assay involves HeLa-CD4 cells (P4 of the tax region (202 nucleotides) (Mahieux et al., 1995)
involved the following primers: Rmtax1 (7784–7805),cells) carrying the bacterial lacZ gene under the control
of the human immunodeficiency virus long terminal 5*ACTAGAATTCGAACGGAAGGAGGCCGTTTTGC3*
sense; and Rmtax2 (7964–7986), 5*TTTGAGCGGCCG-repeat (Charneau et al., 1992) as indicator cells. Tran-
scription of the lacZ gene and cytoplasmic accumula- CACCTCTACCAGCTTT3* antisense. A seminested PCR
was carried out for the env region, with env1 and env22tion of b-galactosidase are strictly dependent upon the
presence of the HIV transactivator Tat. A concentration as the outer primers and env1 and env2 (522 nucleotides)
as the inner primers, as previously described (Mahieuxof 105 of these indicator cells were incubated for 24
hr with 105 CEM-Tat cells, which stably express Tat, et al., 1994): env1 (6023–6045), 5*TCAAGCTATAGTCTC-
CTCCCCCTC3* sense; env2 (6523–6545), 5*GGGAGG-together with 105 of each of the HTLV-I-transformed
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TABLE 1 RESULTS
Characterization of the Three HTLV-I-Transformed Absence of STLV-I infection before inoculation
Squirrel Monkey Cell Lines
PCR using primers which were shown to amplify all
Percentage of T cell the different HTLV-I/STLV-I subtypes did not detect STLV-
surface markers by I provirus in the PBMCs of any monkey prior to inocula-
FACSa
tion (data not shown).IFA ELISA
Cell line CD2 CD4 DR assayb p19c EMd
Characterization of transformed monkey cell lines
EVO/798 94 38 97 / / / producing HTLV-I
EVO/1540 75 75 75 / / /
PBMC from squirrel monkeys cocultivated with irradi-EVO/1715 84 0 86 / / /
ated MT-2 cells exhibited a number of cell clumps after
a Antibodies against human CD3, CD8, CD19, CD25, TCR a/b, and 2 months of in vitro culture, and three continuously grow-
TCR d did not react with monkey lymphoid cells. ing cell lines (named EVO/798, EVO/1540, EVO/1715)b Detected by IF with TSP/HAM patient serum and monoclonal anti-
were established 4 months later. Chromosomal analysisbodies against p19 and p24 gag proteins.
(kindly performed by Isabelle Radford at Laboratoirec p19 in the culture supernatant as measured by a p19 antigen ELISA
capture assay (Cellular Products, USA). d’He´matologie, Hoˆpital Necker, Paris, France) revealed
d EM, viral particles detected by electron microscopy. that these lines had monkey karyotypes (2n  44, data
not shown). FACS analysis of the surface phenotypes
of the lines showed them to be of T-cell lineage, with
TGTCGTAGCTGCAGGAGG3* antisense; and env22 (6752– expression of CD2 and the activation marker HLA-DR but
6773), 5*GGCGAGGTGGAGTCCTTGGAGGC3* antisense. not B cell markers (Table 1).
The amplified products were submitted to electropho- Forty to sixty percent of cells of the three lines pro-
resis on 1.4% agarose gel, transferred to nylon mem- duced HTLV-I p19 and p24 antigens detected by indirect
branes, and hybridized with 32P-labeled internal probes immunofluorescence assay (IFA). The proportion of posi-
for tax, probetax 5*GGGGCCCTAATAATTCTACCCGAA- tive cells was always higher when a polyclonal HTLV-I
GACT3*, and for env, PE1-2 5*CAGACGAGGCCTTGA- human serum was used than with the monoclonal anti
TCTCCTGTT3*. p19, p24 antibodies. At 1 year of culture, 80% of the cells
of the three transformed cell lines were positive by IFA
Cloning and sequencing using a polyclonal HTLV-I human serum. Supernatants
from the three lines were positive in the gag p19 antigen
The cloning procedure was conducted in a laboratory capture assay, and the three cell lines induced syncytium
where HTLV-I has never been amplified or cloned. The formation, indicating the presence of HTLV-I env at the
PCR products were phosphorylated with T4 polynucleo- cell membranes.
tide kinase and ligated with SmaI-digested and dephos- Southern blot analysis showed clonal integration of
phorylated M13mp18 replicative form DNA. After trans- HTLV-I in the three cell lines, with at least one individual
formation of Escherichia coli TG-1, recombinant plaques band migrating at a size greater than 9 kb (size of the
were transferred in situ to nitrocellulose filters and
screened by hybridization with the env-specific oligonu-
cleotide PE1-2 (as described above). Filters were prehy-
bridized at 427 for 1 hr in 41 SSC, 51 Denhardt, 0.5%
SDS and then transferred to a fresh solution containing
in addition the 32P 5* end-labelled probe PE1-2. The filters
were washed with 21 SSC, 0.1% SDS at 427. Positive
plaques were selected and prepared for DNA sequenc-
ing (Sequenase version 2.0; USB) with [a-35S]dATP and
resolved on buffer gels. For each sample, the plasmid
DNA from 16–18 positive recombinant clones was ex-
tracted and sequenced. The percentage of mutated sites
was calculated as follows: all the different mutations ob-
served in the analyzed sequence/length of analyzed se-
FIG. 1. HTLV-I proviral integration as detected by Southern blot inquence 1 number of clones analyzed.
cell lines producing HTLV-I; Lanes: (a) MT-2 human cell line; (b to d)The GenBank accession numbers of the nucleotide
monkey cell lines, (b) EVO/798, (c) EVO/1540, (d) EVO/1715. The DNA
sequences of the monkey HTLV-I env1 and env2 (522 extracted after 6 months of culture was digested with EcoRI restriction
nucleotides), which are different from the HTLV-I-ATK enzyme. The bands detected with the 1711 total genomic probe mi-
grated at a position greater than 9 kb (size of the total HTLV-I provirus).sequence (Seiki et al., 1983), are U73973 to U74016.
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FIG. 2. Antibody response of monkeys against HTLV-I, tested by ELISA after inoculation with autologous, homologous, or heterologous cell lines
producing HTLV-I. (—) ) Monkey 1715 inoculated with EVO/1715; (—l ) monkey 1540 inoculated with EVO/1540; (—j ) monkey 798 inoculated
with EVO/798; (—s ) monkey 1491 inoculated with EVO/798; (—l ) monkey 1657 inoculated with EVO/1540; (—h ) monkey 1561 inoculated with
EVO/1715; (—n ) monkey 1584; (—m ) monkey 1585 inoculated with MT-2 cells.
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ognized only by antibodies present in the sera of the two
monkeys inoculated with homologous transformed cells.
Detection of HTLV-I provirus by PCR
PBMC were obtained from all animals 1 year after
inoculation. Tax sequences of HTLV-I provirus were
detected by PCR in the PBMC from all monkeys inocu-
lated with autologous cells and in two of the three
monkeys inoculated with homologous cells (Fig. 4).
Note the apparently significant difference between
monkeys inoculated with autologous cells (Fig. 4,
lanes a, b, and c) and those infected with homologous
cells (Fig. 4, lanes d and e). In contrast, the HTLV-I
provirus was detected in the PBMC of monkeys inocu-
lated with MT-2 cells 3 weeks after inoculation but not
at 3 months. These seronegative monkeys were killed
6 months after MT-2 injection, and no HTLV-I provirus
was detected in any of the organs examined by PCR
with tax and env primers, including heart, lung, liver,
kidney, spleen, lymph nodes, and the central nervous
system (results not shown).
One of the monkeys inoculated with autologous cells
(monkey 798) died 6 months after inoculation of an acute
renal failure which was clinically and pathologically
proven. No evidence of hematological malignancy wasFIG. 3. Western blot analysis of sera from monkeys inoculated with
detected by anatomopathological or hematological ex-HTLV-I-immortalized homologous and autologous cell lines. Lane 2,
monkey 1491 inoculated with EVO/798; Lane 3, monkey 1561 inoculated aminations; however, HTLV-I provirus was detected by
with EVO/1715; Lane 4, monkey 1657 inoculated with EVO/1540; Lane PCR in the lymph nodes, liver, lung, and kidney, but not
5, monkey 1715 inoculated with EVO/1715; Lane 6, monkey 1540 inocu- in the brain nor any other part of the central nervouslated with EVO/1540; Lane 7, monkey 798 inoculated with EVO/798;
system.Lane 1, positive control HTLV-I-infected human serum.
Evolution of viral load and viral antigen production
As seen in Table 2, the highest proviral load was foundtotal HTLV-I provirus). The patterns of integration in these
in the two monkeys inoculated with homologous HTLV-cell lines were different from those observed with MT-2
I transformed cells, and the level remained stable overcells, suggesting the absence of surviving MT-2 cells in
12 months. The proviral load in the monkeys inoculatedthe cultures (Fig. 1). Viral particles with a diameter of
with autologous cell lines remained very low but was100–150 nm and a structure characteristic of HTLV-I
detectable even 12 months after inoculation.were detected by electron microscopy in all three lines
During 12 weeks of culture of PBMC from the serocon-(micrographs not shown).
verted monkeys, the supernatants were analyzed for
Humoral responses of inoculated monkeys
As seen in Fig. 2, two of the three monkeys inoculated
with homologous cells produced high antibody re-
sponses first detectable 6 weeks after cell inoculation
and beginning to decline after 30–40 weeks. The three
monkeys that received autologous cells developed a low
titer of antibodies, and no HTLV-I antibodies were de-
tected in the two monkeys inoculated with MT-2 cells,
even after six months. As seen in Fig. 3 (Western blot),
FIG. 4. Detection of HTLV-I Tax sequence (202 bp) by PCR in thesera from the two ELISA-positive monkeys inoculated
PBMC of monkeys inoculated with autologous and homologous cellwith homologous cells and from the three monkeys inoc-
line producing HTLV-I. Lanes: (a) monkey 798; (b) monkey 1540; (c)
ulated with autologous cells reacted against gag proteins monkey 1715; (d) monkey 1491; (e) monkey 1657; (f) monkey 1561; (g)
p19 and p24 and recombinant env gp21. In addition, the monkey cell line EVO/798; (h) monkey cell line EVO/1540; (i) monkey
cell line EVO/1715; (j) MT-2 human cell line producing HTLV-I.recombinant env gp46 (amino acids 162–209) was rec-
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TABLE 2
Inoculation Protocol of Squirrel Monkeys with HTLV-I-Producing Cell Lines and Resulting HTLV-I Proviral DNA Copy Numbers
in PBMC of Infected Monkeys at 3, 6, and 12 Months after Inoculation
HTLV-I load (copies/0.7 mg DNA)a
Relationship to No. cells
Monkey No. Cell Lines inoculated monkey inoculated 3 months 6 months 12 months
798 EVO/798 Autologous 108 ND 161 Died
1540 EVO/1540 Autologous 108 ND 10 10
1715 EVO/1715 Autologous 108 ND 10–50 10–50
1491 EVO/798 Homologous 107 237 298 235
1657 EVO/1540 Homologous 107 179 188 154
1561 EVO/1715 Homologous 107 0b 0b 0b
1584 MT-2 Heterologous 107 0b 0b 0b
1585 MT-2 Heterologous 107 0b 0b 0b
Note: ND, not done.
a 0.7 mg DNA corresponded to the amount of genomic DNA extracted from 105 PBMCs.
b Seronegative and PCR-negative monkeys.
HTLV-I p19 antigen. p19 was present continuously in Quasi species and sequence analysis
cultures from monkey 1491, which had been inoculated
Comparison of the sequences of proviral DNA corre-with homologous cells (Fig. 5), but was present only tran-
sponding to the carboxy terminus of the gp46 and thesiently in the cultured PBMC obtained from the other
inoculated monkeys. majority of the gp21 from monkey 1657 3 weeks and 6
FIG. 5. Time course of detection of p19 viral antigen in supernatant of cultured lymphoid T cells from monkey 1941 inoculated with homologous
immortalized cells EVO/798.
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TABLE 3
HTLV-I Quasispecies within the env Gene (522 bp Analyzed)
No. of No. of No. of No. of Percentage of
Isolate studied clones different sequences different mutation mutations per clone mutated sitesa
MT-2 cell line 18 12 10 0.55 0.10
EVO/1540 cell line 18 9 15 0.83 0.15
Monkey 1657b 17 12 25 1.47 0.28
Monkey 1657c 16 11 13 0.81 0.15
a Percentage of mutated sites, No. of different mutation/(522 1 No. of studied clones).
b DNA was extracted from the PBMCs of monkey 1657 at 3 weeks after inoculation with homologous cell line EVO/1540.
c At 6 months after inoculation.
months after inoculation and those from the inoculated gether with high antibody titers, recalled the situation
observed in human HTLV-I carriers (Cimarelli et al., 1995;homologous EVO/1540 cells and from MT-2 cells (Table
3) showed high similarity, with percentage of mutated Miyata et al., 1995). Moreover, by using the same tech-
nique of competitive PCR, we have shown that the provi-sites of 0.10–0.28%. Neither the number of different muta-
tions nor the number of mutations per clone in PBMC ral load in HTLV-I healthy carriers was quite comparable
to that found in HTLV-I-infected squirrel monkeys.from inoculated monkey and the inoculum was signifi-
cantly different. Concerning the variability within each (Angelin-Duclos, in preparation).
The differences observed with autologous and homol-isolate, two minor hypermutated clones (9–12 mutations
leading to 0.28% variability) were found in the PBMC 3 ogous inoculations suggest that squirrel monkeys are
more susceptible to infection with HTLV-I homologousweeks after inoculation. These hypermutated clones
were not detected 6 months after inoculation (data not cells than in autologous cells (which were given at a 10-
fold higher inoculum). In the allogeneic combination, theshown) and the master clone remained the same.
expected strong host response against the foreign major
histocompatibility complex (MHC) antigens on the sur-DISCUSSION
face of the inoculated cells might facilitate viral infection
The results of this study confirm the susceptibility of by providing replicating target lymphocytes in the proxim-
squirrel monkeys to HTLV-I infection, as first shown by ity of the inoculum.
Nakamura et al. (1986), and extend several virological In view of the finding that both rabbits (Miyoshi et al.,
findings. Inoculation of autologous cells resulted in long- 1985) and rats (Ibrahim et al., 1994) are infected after
term infection in the monkeys, with the HTLV-I provirus inoculation of MT-2 cells, it was striking that the two
being present in their PBMC for at least 18 months. There monkeys inoculated with heterologous MT-2 cells failed
was no evidence of even transitory disease in these mon- to seroconvert; HTLV-I provirus was detected in the
keys, despite the fact that some were deliberately ex- PBMC of these monkeys 3 weeks after inoculation, but
posed to a high dose (108) of autologous transformed not thereafter. Interestingly it was also reported that
cells. A similar situation was observed in rabbits by Akagi sheep can be infected with HTLV-I by inoculation with
et al. (1985) and in rats by Yoshiki et al. (1987), who fresh HTLV-I-infected human PBL, but not with MT-2 cells
found that T cells immortalized by HTLV-I in vitro are not (Esteban et al., 1996). Several explanations are possible
tumorigenic in vivo. for the inefficacy of inoculation by MT-2 cells. First, they
It is worth noting that the monkeys inoculated with may have been destroyed by natural antibodies or natural
homologous cells responded to the gp46 epitope, repre- killer cells. Second, since MT-2 cells do not carry monkey
sented by the MTA1 peptide in the Western blot kit, MHC antigens, they would not provoke an allogeneic
whereas those inoculated with autologous cells did not. response. A third possibility is that the passage of HTLV-
This suggests that a high viral load is required to gener- I in squirrel monkey T cells selects a monkey-adapted
ate a response to gp46. A similarly selective absence of HTLV-I variant. We thus explored the genetic variability
response to gp46 was described in Macaca tonkeana of the gp21 region of HTLV-I provirus in the PBMC of
monkeys naturally infected with STLV-I (Ibrahim et al., inoculated monkey compared to the inoculum (homolo-
1995), in HTLV-I-infected rats (Ibrahim et al., 1994) and gous cells) and MT-2 cells. As no significant differences
in healthy human HTLV-II carriers (Lal et al., 1994). At were found, there was no evidence of genetic drift, and
least in the rat model, the lack of response to gp46 was the mutations present in the monkey PBMC 3 weeks
shown to be related to a low viral load (Ibrahim et al., after inoculation did not increase with time, the third
1994). alternative can be ruled out.
The low variability observed in the gp21 region of theThe high proviral load of the inoculated monkeys, to-
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of anti-viral antibody reactivity and detection of virus by gene amplifi-env gene may be related to errors arising during PCR
cation. Int. J. Cancer 45, 127–130.amplification. The errors introduced by Taq polymerase
Dessutti, C. S., Frazier, D. E., Lafrado, L. J., and Olsen, R. G. (1990).
have been found to occur in 1 of 1000 (Pelletier et al., Evaluation of a HTLV-I subunit vaccine in prevention of experimental
1995) or 1 of 3400 (Gessain et al., 1992b) sequenced STLV infection in Macaca nemestrina. J. Med. Primatol. 19, 305–316.
de The´, G., and Kazanji, M. (1996). An HTLV-I vaccine: From animalnucleotides. In this study, about 9000 nucleotides were
models to clinical trials. J. AIDS Hum. Retrovirol. 13(Suppl. 1), 191–sequenced from samples of DNA from each cell type,
198.so three to nine mutations per clone would have been
Esteban, E. N., Sherman, M. P., Poiesz, B. L., Marshak, R. R., Waters,
expected due to error alone. The very low variability ob- D. J., and Ferrer, J. F. (1996). Transmission of Human T Cell Leukemia
served in the analyzed sequences does not suggest that Virus Type I to sheep: Antibody profile and detection of viral DNA
sequences. AIDS Res. Hum. Retroviruses 12, 1717–1724.the HTLV-I env quasispecies should be studied in an-
Garraud, O. (1992). The squirrel monkey Saimiri sciureus: An experi-other HTLV-I-infected squirrel monkey.
mental host for immunological studies on human pathologens. Med.In summary, this study has confirmed that the squirrel
Sci. Res. 20, 3–8.
monkey will provide a useful model system for studying Garraud, O., Groux, H., Poingt, J. P., and Gysin, J. (1990). Limited MHC-
the pathogenesis of HTLV-I and evaluating candidate Class II polymorphism within squirrel monkeys of the same karyo-
type. Med. Sci. Res. 18, 359–361.HTLV-I vaccines. Unlike Old World primates, the New
Garraud, O., Perraut, R., Gysin, J., Behr, C., Dubois, P., Bonnemains, B.,World squirrel monkeys are free of infection with STLV-
Jouin, H., Michel, J-C., and Pereira da Silva, L. (1994). ManipulationI, which has a very close genetic and immunological
blood T cells and B cells from squirrel monkeys: Some technical
relationship to HTLV-I. The basic immunological parame- consideration. J. Immunol. Methods 173, 165–173.
ters of squirrel monkeys, including immunoglobulin sub- Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A.,
and de The´, G. (1985). Antibodies to human T-lymphotropic virusclasses, markers for lymphocyte subsets, and MHC anti-
type-I in patients with tropical spastic paraparesis. Lancet ii, 407–gens have been characterized (Garraud et al., 1990, 1992,
410.1994). Our study has shown that inoculation of homolo-
Gessain, A., Caumes, E., Feyeux, C., D’agay, M. F., Capesius, C., Gentil-
gous (allogeneic) HTLV-I-transformed cells can lead to ini, M., and Morel, P. (1992a). The cutaneous form of adult T-cell
chronic infection in these monkeys. Use of allogeneic leukemia/lymphoma in a woman from the Ivory Coast. Clinical immu-
novirologic studies and a review of the African adult T-cell-leukemia/cells is not only experimentally more convenient than
lymphoma cases. Cancer 69, 1362–1367.use of autologous cells but it also conforms to the natural
Gessain, A., Gallo, R. C., and Franchini, G. (1992b). Low degree ofpattern of infection between unrelated people.
human T-cell leukemia/lymphoma virus type I genetic drift in vivo as
a means of monitoring viral transmission and movement of ancient
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